|
|
Research Progress and Trends of Intelligent Speech in Pathological Healthcare
Gao Yingming, Wu Yangqing, Yang Fei, Zhou Yingying, Li Ya, Wu Mengyue
2026, 31 (3):
671-692.
doi: 10.1007/s12204-026-2943-8
Intelligent speech technology, rooted in the ancient medical practice of “auscultation and interrogation”, is emerging as a transformative tool in modern pathological healthcare. By analyzing acoustic biomarkers within speech, voice, cough, breath sounds, and heart sounds, it offers a non-invasive, cost-effective avenue for early screening, auxiliary diagnosis, monitoring, and rehabilitation assessment across a wide spectrum of conditions, including mental disorders, neurodegenerative diseases, respiratory illnesses, cardiovascular diseases, and laryngeal or vocal tract pathologies. This study comprehensively reviews the research progress and prevailing trends in this interdisciplinary field. It begins by elucidating the physiological basis of pathological acoustics, including neural dysregulation, airway and pulmonary abnormalities, hemodynamic disturbances, and laryngeal or vocal tract dysfunction, and then discusses its integration with AI-driven diagnostics. The core of the review systematically details advances in two pillars: data resource construction (encompassing datasets for various diseases and standardization efforts) and methodological innovation (tracking the paradigm shift from feature-based machine learning to deep learning, self-supervised models, and multimodal large language models). Furthermore, it explores the development of intelligent speech-driven intervention systems for mental health. The analysis identifies key dynamic trends: the evolution from single-modality to multimodal analysis, the shift from strong to weak/self-supervised learning, the transition from controlled lab settings to naturalistic scenarios, the growing priority of model interpretability, and the move towards multi-disease coexistence modeling. Despite promising clinical potential, significant challenges persist, including data scarcity, algorithmic robustness, and clinical integration bottlenecks. The study concludes by outlining critical future directions: fostering federated learning and multi-center validation, enhancing explainable AI fused with medical knowledge, improving cross-device and cross-environment robustness through hardware-software co-design, refining human-AI collaborative diagnostic paradigms, and establishing comprehensive standardization and regulatory frameworks. Overcoming these hurdles through concerted interdisciplinary efforts is essential to realize a full-cycle intelligent health ecosystem, advancing precision medicine and equitable healthcare delivery.
References |
Related Articles |
Metrics
|